Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Chuang Patrick T.Senior VP, Memory Design | Grant or award | A | — 20.0K sh | Feb 4, 2026 |
| 5 | Bharucha DavidChief Medical Officer | Grant or award | A | — 136.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Bharucha DavidChief Medical Officer | Grant or award | A | — 204.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Zojwalla NaseemCHIEF MEDICAL OFFICER | Grant or award | A | — 250.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Nelson Jeffrey EdwardChief Operating Officer | Grant or award | A | — 204.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Heeson LeeEVP, Head of Incyte Intl | Tax withholding | F | $11K 111 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Thompson Travis AlvinChief Financial Officer | Grant or award | A | — 58.0K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 5 | Savitz RyanEVP, CFO & CBO | Grant or award | A | — 150.0K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 5 | Saldanha CraigChief Product Officer | Open-market sale · 10b5-1 plan | SELL | $33K 1,200 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Randhawa SimratEVP, Head of R&D | Grant or award | A | — 150.0K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 5 | Novack Jeffrey AdamSecretary and General Counsel | Grant or award | A | — 4,342 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Naude PierreDirector | Grant or award | A | — 3,516 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Russotti GregorySee Remarks | Grant or award | A | — 265.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Zojwalla NaseemCHIEF MEDICAL OFFICER | Grant or award | A | — 106.3K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Vultaggio VincentPAO and PFO | Open-market sale · 10b5-1 plan | SELL | $6,477 2,540 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Nelson Jeffrey EdwardChief Operating Officer | Grant or award | A | — 136.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 3 | Remer Eric RichardDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $30K 2,797 sh | Feb 4, 2026 traded Feb 4, 2026 |
| 3 | Remer Eric RichardDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $20K 1,700 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 3 | Bachrodt AmySVP, Finance | Option exercise · 10b5-1 plan | M | $50K 4,844 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 2 | Allaire JeremyDirector, Chairman and CEO | Option exercise | M | — 15.2K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 2 | Allaire JeremyDirector, Chairman and CEO | Option exercise | M | — 6,742 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 2 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Grant or award | A | — 106.3K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 2 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Grant or award | A | — 250.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 2 | Holleran KevinDirector, President and CEO | Option exercise · 10b5-1 plan | M | $73K 52.4K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 2 | Allaire JeremyDirector, Chairman and CEO | Option exercise | M | — 6,017 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 1 | Vultaggio VincentPAO and PFO | Open-market sale · 10b5-1 plan | SELL | $1,398 556 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 1 | Kozarich John WDirector | Open-market sale · 10b5-1 plan | SELL | $75K 381 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 1 | Sieffert Kristen NPresident | Open-market sale · 10b5-1 plan | SELL | $17K 750 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 1 | Barrett David MichaelDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $44K 30.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Fang AndyDirector | Other acquisition or disposition · 10b5-1 plan | J | — 10.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Tang StanleyDirector | Other acquisition or disposition · 10b5-1 plan | J | — 45.4K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | Open-market sale · 10b5-1 plan | SELL | $7,449 39 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | Open-market sale · 10b5-1 plan | SELL | $4,499 23 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Bachrodt AmySVP, Finance | Option exercise · 10b5-1 plan | M | — 4,844 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Holleran KevinDirector, President and CEO | Option exercise · 10b5-1 plan | M | — 52.4K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Alpern Paul LVP and General Counsel | Option exercise · 10b5-1 plan | M | $2,800 5,000 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO | Option exercise · 10b5-1 plan | M | — 15.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Fang AndyDirector | Other acquisition or disposition · 10b5-1 plan | J | — 10.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Wampler Kira SchererDirector | Derivative conversion · 10b5-1 plan | C | — 2,000 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Alpern Paul LVP and General Counsel | Option exercise · 10b5-1 plan | M | — 5,000 sh | Feb 4, 2026 traded Feb 2, 2026 |